These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 9093257)

  • 1. 32 bp CCR-5 gene deletion and resistance to fast progression in HIV-1 infected heterozygotes.
    Rappaport J; Cho YY; Hendel H; Schwartz EJ; Schachter F; Zagury JF
    Lancet; 1997 Mar; 349(9056):922-3. PubMed ID: 9093257
    [No Abstract]   [Full Text] [Related]  

  • 2. HIV-1 infection in an individual homozygous for the CCR5 deletion allele.
    Biti R; Ffrench R; Young J; Bennetts B; Stewart G; Liang T
    Nat Med; 1997 Mar; 3(3):252-3. PubMed ID: 9055842
    [No Abstract]   [Full Text] [Related]  

  • 3. Resistance to HIV-1 infection: it's in the genes.
    Fauci AS
    Nat Med; 1996 Sep; 2(9):966-7. PubMed ID: 8782446
    [No Abstract]   [Full Text] [Related]  

  • 4. CCR5-delta 32 gene deletion in HIV-1 infected patients.
    Wang B; Palasanthiran P; Zeigler J; Cunningham A; Saksena NK
    Lancet; 1997 Sep; 350(9079):742. PubMed ID: 9291932
    [No Abstract]   [Full Text] [Related]  

  • 5. CCR5-delta 32 gene deletion in HIV-1 infected patients.
    Michael NL; Louie LG; Sheppard HW
    Lancet; 1997 Sep; 350(9079):741-2. PubMed ID: 9291931
    [No Abstract]   [Full Text] [Related]  

  • 6. CCR5-delta 32 gene deletion in HIV-1 infected patients.
    Smith MW; Dean M; Carrington M; Huttley GA; O'Brien SJ
    Lancet; 1997 Sep; 350(9079):741; author reply 742. PubMed ID: 9291930
    [No Abstract]   [Full Text] [Related]  

  • 7. HIV-1 infection in an individual homozygous for CCR5 delta 32. Seroco Study Group.
    Theodorou I; Meyer L; Magierowska M; Katlama C; Rouzioux C
    Lancet; 1997 Apr; 349(9060):1219-20. PubMed ID: 9130946
    [No Abstract]   [Full Text] [Related]  

  • 8. Early protective effect of CCR-5 delta 32 heterozygosity on HIV-1 disease progression: relationship with viral load. The SEROCO Study Group.
    Meyer L; Magierowska M; Hubert JB; Rouzioux C; Deveau C; Sanson F; Debre P; Delfraissy JF; Theodorou I
    AIDS; 1997 Sep; 11(11):F73-8. PubMed ID: 9302436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of a mutant CCR5 allele in HIV-1 transmission and disease progression.
    Huang Y; Paxton WA; Wolinsky SM; Neumann AU; Zhang L; He T; Kang S; Ceradini D; Jin Z; Yazdanbakhsh K; Kunstman K; Erickson D; Dragon E; Landau NR; Phair J; Ho DD; Koup RA
    Nat Med; 1996 Nov; 2(11):1240-3. PubMed ID: 8898752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual effect of CCR5 delta 32 gene deletion in HIV-1-infected patients. Copenhagen AIDS Study Group.
    Garred P; Eugen-Olsen J; Iversen AK; Benfield TL; Svejgaard A; Hofmann B
    Lancet; 1997 Jun; 349(9069):1884. PubMed ID: 9217763
    [No Abstract]   [Full Text] [Related]  

  • 11. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study.
    Dean M; Carrington M; Winkler C; Huttley GA; Smith MW; Allikmets R; Goedert JJ; Buchbinder SP; Vittinghoff E; Gomperts E; Donfield S; Vlahov D; Kaslow R; Saah A; Rinaldo C; Detels R; O'Brien SJ
    Science; 1996 Sep; 273(5283):1856-62. PubMed ID: 8791590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural resistance to HIV?
    Hill CM; Littman DR
    Nature; 1996 Aug; 382(6593):668-9. PubMed ID: 8751431
    [No Abstract]   [Full Text] [Related]  

  • 13. HIV-1 infection in a man homozygous for CCR5 delta 32.
    O'Brien TR; Winkler C; Dean M; Nelson JA; Carrington M; Michael NL; White GC
    Lancet; 1997 Apr; 349(9060):1219. PubMed ID: 9130945
    [No Abstract]   [Full Text] [Related]  

  • 14. AIDS research. Receptor mutations help slow disease progression.
    Cohen J
    Science; 1996 Sep; 273(5283):1797-8. PubMed ID: 8815542
    [No Abstract]   [Full Text] [Related]  

  • 15. Intact CCR-5 coreceptors in HIV-1-infected chimpanzees.
    ten Haaft PJ; Murthy KK; Verstrepen BE; Eichberg JW; Heeney JL
    AIDS; 1997 Aug; 11(10):1291-3. PubMed ID: 9256948
    [No Abstract]   [Full Text] [Related]  

  • 16. HIV-1-resistant individuals may lack HIV-1 coreceptor.
    Bradbury J
    Lancet; 1996 Aug; 348(9025):463. PubMed ID: 8709791
    [No Abstract]   [Full Text] [Related]  

  • 17. Host genes and HIV: the role of the chemokine receptor gene CCR5 and its allele.
    McNicholl JM; Smith DK; Qari SH; Hodge T
    Emerg Infect Dis; 1997; 3(3):261-71. PubMed ID: 9284370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Homozygous delta 32 deletion of the CCR-5 chemokine receptor gene in an HIV-1-infected patient.
    Balotta C; Bagnarelli P; Violin M; Ridolfo AL; Zhou D; Berlusconi A; Corvasce S; Corbellino M; Clementi M; Clerici M; Moroni M; Galli M
    AIDS; 1997 Aug; 11(10):F67-71. PubMed ID: 9256936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inherited resistance to HIV-1 conferred by an inactivating mutation in CC chemokine receptor 5: studies in populations with contrasting clinical phenotypes, defined racial background, and quantified risk.
    Zimmerman PA; Buckler-White A; Alkhatib G; Spalding T; Kubofcik J; Combadiere C; Weissman D; Cohen O; Rubbert A; Lam G; Vaccarezza M; Kennedy PE; Kumaraswami V; Giorgi JV; Detels R; Hunter J; Chopek M; Berger EA; Fauci AS; Nutman TB; Murphy PM
    Mol Med; 1997 Jan; 3(1):23-36. PubMed ID: 9132277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new CX3 CR1 genotype with implications for HIV disease progression.
    Roman F; Deroo S; Franck N; Burgy C; Servais J; Schmit JC
    AIDS; 2001 Mar; 15(5):659-60. PubMed ID: 11317010
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.